Oceans Omega Overview

  • Year Founded
  • 2009

Year Founded

  • Status
  • Out of Business

  • Employees
  • 2

Employees

  • Latest Deal Type
  • Out of Business

Oceans Omega General Information

Description

Operator of a biotechnology company intended to provide liquid Omega-3 ingredients for the food and beverage industry. The company's offerings include a range of stable Omega-3 emulsions that are water-soluble and crystal clear in finished products and have no impact on taste, odor, appearance, or texture, enabling consumers to get Omega-3 in shelf-stable liquid products.

Contact Information

Ownership Status
Out of Business
Financing Status
Formerly VC-backed
Corporate Office
  • 521 Fifth Avenue
  • Floor 21
  • New York, NY 10175
  • United States
+1 (212)
Primary Industry
Other Pharmaceuticals and Biotechnology
Corporate Office
  • 521 Fifth Avenue
  • Floor 21
  • New York, NY 10175
  • United States
+1 (212)

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Oceans Omega Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
8. Out of Business 20-May-2025 Completed Out of Business
7. PE Growth/Expansion 01-Jan-2016 Cancelled Generating Revenue
6. Later Stage VC 27-Jan-2016 Completed Generating Revenue
5. Later Stage VC 30-Dec-2014 Completed Generating Revenue
4. Angel (individual) 14-Jan-2013 Completed Generating Revenue
3. Early Stage VC 26-Jul-2012 Completed Generating Revenue
2. Angel (individual) 16-Jul-2012 $350K $3.85M Completed Generating Revenue
1. Seed Round 11-Mar-2010 $3.5M $3.5M Completed Generating Revenue
To view Oceans Omega’s complete valuation and funding history, request access »

Oceans Omega Patents

Oceans Omega Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
AU-2016268256-A1 Mono and di-glyceride esters of omega-3 fatty acid emulsions Inactive 25-May-2015
EP-3302083-A1 Mono and di-glyceride esters of omega-3 fatty acid emulsions Inactive 25-May-2015
US-20160345618-A1 Mono and di-glyceride esters of omega-3 fatty acid emulsions Inactive 25-May-2015
WO-2016191433-A1 Mono and di-glyceride esters of omega-3 fatty acid emulsions Inactive 25-May-2015
AU-2012253281-A1 Formulations of phospholipid comprising omega fatty acids Inactive 12-May-2011 A23D9/05
To view Oceans Omega’s complete patent history, request access »

Oceans Omega Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Oceans Omega FAQs

  • When was Oceans Omega founded?

    Oceans Omega was founded in 2009.

  • Where is Oceans Omega headquartered?

    Oceans Omega is headquartered in New York, NY.

  • What is the size of Oceans Omega?

    Oceans Omega has 2 total employees.

  • What industry is Oceans Omega in?

    Oceans Omega’s primary industry is Other Pharmaceuticals and Biotechnology.

  • Is Oceans Omega a private or public company?

    Oceans Omega is a Private company.

  • What is Oceans Omega’s current revenue?

    The current revenue for Oceans Omega is .

  • How much funding has Oceans Omega raised over time?

    Oceans Omega has raised $22.3M.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process